Clinical Trial Update: High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial from Yonsei University found that high-dose intravenous ascorbic acid reduced mitochondrial DNA damage in patients with chronic fatig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome

Drugs mentioned

• Ascorbic acid (intravenous) (ascorbic acid)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Fatigue | Phase 4 | Status: UNKNOWN